Details for New Drug Application (NDA): 022504
✉ Email this page to a colleague
The generic ingredient in AXIRON is testosterone. There are sixty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 022504
Tradename: | AXIRON |
Applicant: | Eli Lilly And Co |
Ingredient: | testosterone |
Patents: | 6 |
Medical Subject Heading (MeSH) Categories for 022504
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION, METERED;TRANSDERMAL | Strength | 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Nov 23, 2010 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 26, 2027 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF A PERSON IN NEED THEREOF | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 27, 2027 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF AN ADULT MALE SUBJECT IN NEED THEREOF | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 26, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | A METHOD OF TRANSDERMAL ADMINISTRATION OF A PHYSIOLOGICALLY ACTIVE AGENT TO A SUBJECT. |
Expired US Patents for NDA 022504
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Eli Lilly And Co | AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504-001 | Nov 23, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Eli Lilly And Co | AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504-001 | Nov 23, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Eli Lilly And Co | AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504-001 | Nov 23, 2010 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription